Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
... of the particle accelerator that will deliver proton therapy at a number of hospitals beginning with ... bring us to system integration and delivery." proton therapy, widely regarded as the next evolutionary ... However, the large size and high cost of existing proton therapy systems have made it difficult for the ...New Proton Therapy Equipment Enables More Tumors to be Treated
... are delivered at the University of Florida proton Therapy Institute enables physicians to treat ... commonly used scattering method. Until now the proton beam was "scattered" and flattened using round ... wide protons could travel into the body. proton therapy will now be a possible treatment option ...AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
... bleeding (PUB).(1) To date, there is no proton pump inhibitor (PPI) therapy globally approved ... et al. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the ... (11) Barkun et al. High-dose intravenous proton pump inhibition following endoscopic ...IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
... to optimize the seamless integration of proton therapy delivery and information management ... management and information system (OIS), MOSAIQ proton Therapy module, patient immobilization devices, ... solutions to an extended market. "The IBA proton therapy solution is intrinsically open to ...Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
... patients not taking the drugs. Diabetes Patients on Clopidogrel and proton Pump Inhibitors at Greater Risk for Cardiovascular Events New research ... diabetes who take clopidogrel (the active ingredient in Plavix(R)) and proton pump inhibitors (PPIs) together. A growing body of evidence highlights ...Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
... MRI Breast Spectroscopy A recent study published in Radiology found that proton MRI spectroscopy may eliminate 68 percent of biopsies for benign ... L, et al "Enhancing Nonmass Lesions in the Breast: Evaluation with proton 1(H) MR Spectroscopy" Radiology 2007; 245: 80-87. About Siemens Medical ...AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
... As with all PPIs, patients treated concomitantly with warfarin may need to be monitored for increases in INR and prothrombin time. Like other proton pump inhibitors, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ...Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
... esophagus. Approximately 19 million adults in the U.S. suffer on a daily basis from the symptoms of GERD. Medical therapy, such as the daily use of proton pump inhibitors (PPIs), may improve heartburn symptoms but it does not address the mechanically defective sphincter, allowing gastric reflux to ...Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
... Center(TM) at Swedish Medical Center, and Northwest Hospital Gamma Knife Center. SCI is also working toward adding the latest generation of proton beam radiotherapy systems to this arsenal of cancer-fighting tools by December 2010. ...POZEN Announces Positive Outcome for PA 325 Proof of Concept Study
... surrounded by a 20mg coating of an immediate release formulation of a proton pump inhibitor. The PA 325, 28 day study, involved two groups of 40 ... for proprietary fixed dose combinations of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions ...Pozen Announces Positive Outcome for PA 325
... fourth quarter of 2006. PA 325 is a patented formulation of 325mg of aspirin surrounded by a 20mg coating of an immediate release formulation of a proton pump inhibitor. The PA 325, 28 day study, involved two groups of 40 subjects over the age of 50. Each subject was treated with either once a ...Eurand Announces Positive Phase III Clinical Study Results
... the study, the level of fat absorption achieved with Zentase was very high and close to levels seen in healthy patients, even without the use of proton pump inhibitors (PPIs). This high fat absorption, without relying on PPIs could significantly reduce the number of pills patients take each day." ...Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
... including antidepressants, anti-psychotics, anti-arrhythmics, and beta-blockers. The second, CYP2C19, metabolizes anticoagulants, anticonvulsants, proton pump inhibitors, benzodiazepines, anti-malarials, and other medications. The literature has shown that a genotype screen, such as the AmpliChip CYP ...